Biomaterials are natural or synthetic substances engineered to interact with biological systems for medical purposes, including the diagnosis, treatment, repair, or replacement of tissues and organs. The field sits at the intersection of materials science, biology, chemistry, and medicine, drawing on principles from each discipline to design materials that perform reliably within the complex environment of the human body. From ancient sutures made of animal sinew to modern drug-eluting stents and tissue-engineered scaffolds, the history of biomaterials reflects humanity's enduring effort to restore function and alleviate suffering through material innovation.
The science of biomaterials is governed by the concept of biocompatibility, the ability of a material to perform its intended function without eliciting an undesirable local or systemic response in the host. Biomaterials are broadly classified into metals (such as titanium and cobalt-chromium alloys used in orthopedic implants), ceramics (such as hydroxyapatite for bone repair), polymers (such as polyethylene glycol and polylactic acid for drug delivery and tissue scaffolds), and composites that combine multiple material types. Each class offers distinct advantages in terms of mechanical strength, degradation behavior, and biological interaction, and the choice of material depends on the specific clinical application and the mechanical and biological demands of the implant site.
Today, biomaterials research is advancing rapidly into areas such as smart and responsive materials that release drugs in response to physiological triggers, three-dimensional bioprinting of tissue constructs, nanostructured surfaces that direct stem cell differentiation, and bioresorbable implants that dissolve safely after healing is complete. Regulatory science, including biocompatibility testing standards set by organizations such as the International Organization for Standardization (ISO 10993), plays a critical role in translating laboratory discoveries into clinical products. The field continues to grow in importance as aging populations, rising rates of chronic disease, and advances in regenerative medicine drive demand for next-generation implants and therapies.